Aadi Bioscience (AADI) Earnings Date, Estimates & Call Transcripts $1.65 0.00 (0.00%) As of 08/20/2025 Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aadi Bioscience Earnings Summary Aadi Bioscience announced Q4 2024 earnings on March 18, 2025, reporting an EPS of -$0.67, which missed analysts' consensus estimates of -$0.30 by $0.37. Quarterly revenue was reported to be $7.24 million, below analysts' expectations of $7.45 million. With a trailing EPS of -$2.35, Aadi Bioscience's earnings are expected to grow next year, from ($2.04) to ($0.94) per share. Upcoming Earnings DateNov. 4Before Market OpensEstimatedConsensus EPS (Mar. 18) -$0.30 Actual EPS (Mar. 18) -$0.67 Missed By -$0.37 Actual Revenue (Mar. 18) $7.24MQ4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)AADI Upcoming EarningsAadi Bioscience's next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules. Powered by Get Aadi Bioscience Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aadi Bioscience and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAADI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AADI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Aadi Bioscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.17-$0.17-$0.17Q2 20251-$0.18-$0.18-$0.18Q3 20251-$0.18-$0.18-$0.18Q4 20251-$0.19-$0.19-$0.19 Aadi Bioscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/4/2025(Estimated)--------3/18/2025Q4 2024-$0.30-$0.67 -$0.37-$0.67$7.45M$7.24M11/6/2024Q3 2024-$0.46-$0.46--$0.46$6.55M$7.21M8/7/2024Q2 2024-$0.71-$0.54+$0.17-$0.54$6.33M$6.18M5/8/2024Q1 2024-$0.66-$0.68 -$0.02-$0.68$6.41M$5.35M3/13/2024Q4 2023-$0.67-$0.60+$0.07-$0.60$6.46M$6.33M11/8/2023Q3 2023-$0.73-$0.60+$0.13-$0.60$6.68M$5.96M Aadi Bioscience Earnings - Frequently Asked Questions When is Aadi Bioscience's earnings date? Aadi Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 4th, 2025 based off last year's report dates. Learn more on AADI's earnings history. Did Aadi Bioscience beat their earnings estimates last quarter? In the previous quarter, Aadi Bioscience (NASDAQ:AADI) missed the analysts' consensus estimate of ($0.30) by $0.37 with a reported earnings per share (EPS) of ($0.67). Learn more on analysts' earnings estimate vs. AADI's actual earnings. How can I listen to Aadi Bioscience's earnings conference call? The conference call for Aadi Bioscience's latest earnings report can be listened to online. Listen to Conference Call How can I read Aadi Bioscience's conference call transcript? The conference call transcript for Aadi Bioscience's latest earnings report can be read online. Read Transcript How much revenue does Aadi Bioscience generate each year? Aadi Bioscience (NASDAQ:AADI) has a recorded annual revenue of $25.07 million. How much profit does Aadi Bioscience generate each year? Aadi Bioscience (NASDAQ:AADI) has a recorded net income of -$65.76 million. AADI has generated -$2.35 earnings per share over the last four quarters. What is Aadi Bioscience's EPS forecast for next year? Aadi Bioscience's earnings are expected to grow from ($2.04) per share to ($0.94) per share in the next year. More Earnings Resources from MarketBeat Related Companies Lyell Immunopharma Earnings MEI Pharma Earnings Lifevantage Earnings Contineum Therapeutics Earnings Actuate Therapeutics Earnings Greenwich LifeSciences Earnings Eledon Pharmaceuticals Earnings Rapt Therapeutics Earnings Caribou Biosciences Earnings Cardiff Oncology Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? This page (NASDAQ:AADI) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access